In vitro activities of semisynthetic pneumocandin L-733,560 against fluconazole-resistant and -susceptible Candida albicans isolates

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 5, 1996, Pages 1277-1279

  Martinez Suarez, Joaquin V ^a   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; L 733560; PNEUMOCANDIN DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; DOSE RESPONSE; DRUG EFFECT; DRUG POTENCY; DRUG RESISTANCE; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0029866830     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.5.1277     Document Type: Article

References (20)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L, Kong, J. G. Smith, D. Krupa, V. B. Pikounis, H. Kropp, and K. Bartizal. 1995. Evaluation of water-soluble pneumocandin analogs L-733,560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis Antimicrob Agents Chemother. 39:1077-1081.
2. Anaissie, E., V. Paetznick, and G. P. Bodey. 1990 Fluconazole susceptibility testing of Candida albicans. microtiter method that is independent of inoculum size, temperature, and time of reading. Antimicrob. Agents Chemother. 35:1641-1646.
3. Anaissie, E. J., N. C. Karyotakis, R. Hachem, M. C. Dignani, J. H. Rex, and V. Paetznick. 1994 Correlation between in vitro and in vivo activity of antifungal agents against Candida species. J. Infect. Dis. 170:384-389.
4. Barchiesi, F., A. L. Colombo, D. A. Mcgough, A. W. Fothergill, and M. G. Rinaldi. 1994 In vitro activity of itraconazole against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus. Antimicrob. Agents Chemother 38: 1530-1533.
5. Bartizal, K., T. Scott, G. K. Abruzzo, C. J. Gill, C. Pacholok, L. Lynch, and H. Kropp. 1995. In vitro evaluation of the pneumocandin antifungal agent L-733,560, a new water-soluble hybrid of L-705589 and L-731373. Antimicrob Agents Chemother. 39:1070-1076
6. Debono, M., and R. S. Gordee. 1994. Antibiotics that inhibit fungal cell wall development Annu. Rev. Microbiol. 48:471-497.
7. Espinel-Ingroff, A., and M. A. Pfaller. 1995. Antifungal agents and susceptibility testing, p. 1405-1421. In P. K. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H Yolken (ed.), Manual of clinical microbiology. 6th ed ASM Press, Washington, D.C
8. Espinel-Ingroff, A., J. L. Rodriguez-Tudela, and J. V. Martínez-Suárez. 1995. Comparison of two alternative microdilution procedures with the National Committee for Clinical Laboratory Standards reference macrodilution method M27-P for in vitro testing ot fluconazole-resistant and -susceptible isolates of Candida albicans J Clin. Microbiol. 33:3154-3158.
9. Kurtz, M. B., E. M. Bernard, F. F. Edwards, J. A. Marrinan, J. Dropinski, C. M. Douglas, and D. Armstrong. 1995. Aerosol and parenteral pneumocandins are effective in a rat model of pulmonary aspergillosis. Antimicrob. Agents Chemother 39:1784-1789.
10. Kurtz, M. B., C. Douglas, J. Marrinan, K. Nollstadt, J. Onishi, S. Dreikorn, J. Milligan, S. Mandala, J. Thompson, J. M. Balkovec, F. A. Bouffard, J. F. Dropinski, M. L. Hammond, R. A. Zambias, G. Abruzzo, K. Bartizal, O. B. Mcmanus, and M. L. Garcia. 1994 Increased antifungal activity of L-733,560, a water-soluble. semysinthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis. Antimicrob. Agents Chemother 38:2750-2757.
11. Martínez-Suárez, J. V., and J. L. Rudriguez-Tudela. 1995. Patterns of in vitro activity of itraconazole and imidazole antifungal agents against Candida albicans with decreased susceptibility to fluconazole from Spain. Antimicrob. Agents Chemother 39:1512-1516
12. McIntyre, K. A., and J. N. Galgiani. 1989 pH and other effects on the antifungal activity of cilofungin (LY121019). Antimicrob. Agents Chemother. 33:732-735.
13. National Committee for Clinical Laboratory Standards. 1992 Reference method for broth dilution antifungal susceptibility testing of yeasts. Proposed standard M27-P National Committee for Clinical Laboratory Standards, Villanova. Pa.
14. Odds, F. C. 1993. Resistance of yeasts to azole-derivative antifungals. J. Antimicrob. Chemother. 31:463-471
15. Pfaller, M. A., M. Bale, B. Buschelman, M. Lancaster, A. Espinel-Ingroff, J. H. Rex, M. G. Rinaldi, C. R. Cooper, and M. R. McGinnis. 1995. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B. fluconazole. and flucytosine J. Clin. Microbiol. 33:1104-1107.
16. Rev J. H., M. A, Pfaller, M. G. Rinaldi, A. Polak, and J. N. Galgiani. 1993 Antifungal susceptibility testing. Clin. Microbiol. Rev 6:371-381.
17. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995 Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
18. Rodriguez-Tudela, J. L., and J. V. Martínez-Suárez. 1995. Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria. J. Antimicrob. Chemother. 35:739-749
19. Rodríguez-Tudela, J. L., J. V. Martínez-Suárez, F. Dronda, F. Laguna, F. Chaves, and E. Valencia. 1995 Correlation of in-vitro susceptibility test results with clinical response: a study of azole therapy in AIDS patients. J. Antimicrob Chemother. 35:793-804.
20. Schmatz, D. M., M. A. Powles, D. McFadden, K. Nollstadt, F. A. Bouffard, J. F. Dropinski, P. Liberator, and J. Anderson. 1995. New scmisynthetic pneumocandins with improved efficacies against Pneumocystis cannii in the rat. Antimicrob. Agents Chemother. 39:1320-1323.